Sangamo Therapeutics To Present At The 36th Annual J.P. Morgan Healthcare Conference

RICHMOND, Calif., Jan. 4, 2018 /PRNewswire/ -- Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today that Dr. Sandy Macrae, CEO of Sangamo, will present at the 36^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10^th at 4:00 p.m. PT. Dr. Macrae's presentation will be followed by a separate Q&A session starting at 4:30 p.m. PT. The conference is being held in San Francisco, CA from January 8-11, 2018.

The presentation and Q&A session will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo Therapeutics
Sangamo Therapeutics, Inc. is focused on translating ground-breaking science into genomic therapies that transform patients' lives using the company's industry leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. For more information about Sangamo, visit www.sangamo.com.

 

View original content with multimedia:http://www.prnewswire.com/news-releases/sangamo-therapeutics-to-present-at-the-36th-annual-jp-morgan-healthcare-conference-300577746.html

SOURCE Sangamo Therapeutics, Inc.

Copyright 2018 PR Newswire